Monday, March 27, 2017

The Pharmacogenomics Journal - Table of Contents alert Volume 17 Issue 2

If you are unable to see the message below, click here to view.
The Pharmacogenomics Journal

NYU Nature Conference on Neurogenetics 

August 9-11, 2017| New York, NY

Presented by: New York University (NYU) | Nature Genetics | Nature Neuroscience 

Register now!


Volume 17, Issue 2 (March 2017)

In this issue
News and Commentary
Original Articles
Consensus Article

Also new
A new open access journal dedicated to publishing the most important scientific advances in all aspects of genomics and its application in the practice of medicine.

Part of the Nature Partner Journals series, the journal is published in partnership with the Center of Excellence in Genomic Medicine Research. 

Open for submissions >>
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed

News and Commentary


Tamoxifen metabolism in breast cancer treatment: Taking the focus off the CYP2D6 gene

A Novillo, A Romero-Lorca, M Gaibar, M Rubio and A Fernández-Santander

Pharmacogenomics J 2016 17: 109-111; advance online publication, October 4, 2016; 10.1038/tpj.2016.73

Full Text



Pharmacogenomic implications of the evolutionary history of infectious diseases in Africa OPEN

J L Baker, D Shriner, A R Bentley and C N Rotimi

Pharmacogenomics J 2016 17: 112-120; advance online publication, October 25, 2016; 10.1038/tpj.2016.78

Abstract | Full Text

Original Articles


Health regulatory communications of well-established safety-related pharmacogenomics associations in six developed countries: an evaluation of alignment

W C Tan-Koi, Evelyn S H Lim and Y Y Teo

Pharmacogenomics J 2016 17: 121-127; advance online publication, February 23, 2016; 10.1038/tpj.2016.5

Abstract | Full Text

Impact of germline and somatic missense variations on drug binding sites OPEN

C Yan, N Pattabiraman, J Goecks, P Lam, A Nayak, Y Pan, J Torcivia-Rodriguez, A Voskanian, Q Wan and R Mazumder

Pharmacogenomics J 2016 17: 128-136; advance online publication, January 26, 2016; 10.1038/tpj.2015.97

Abstract | Full Text

Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines OPEN

A Chhibber, C E French, S W Yee, E R Gamazon, E Theusch, X Qin, A Webb, A C Papp, A Wang, C Q Simmons, A Konkashbaev, A S Chaudhry, K Mitchel, D Stryke, T E Ferrin, S T Weiss, D L Kroetz, W Sadee, D A Nickerson, R M Krauss, A L George, E G Schuetz, M W Medina, N J Cox, S E Scherer, K M Giacomini and S E Brenner

Pharmacogenomics J 2016 17: 137-145; advance online publication, February 9, 2016; 10.1038/tpj.2015.93

Abstract | Full Text

The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis

E Sacchetti, C Magri, A Minelli, P Valsecchi, M Traversa, S Calza, A Vita and M Gennarelli

Pharmacogenomics J 2016 17: 146-154; advance online publication, February 9, 2016; 10.1038/tpj.2015.90

Abstract | Full Text

A longitudinal study of the association between the GNB3 C825T polymorphism and metabolic disturbance in bipolar II patients treated with valproate

P S Chen, H H Chang, C-C Huang, C C Lee, S-Y Lee, S-L Chen, S-Y Huang, Y K Yang and R-B Lu

Pharmacogenomics J 2016 17: 155-161; advance online publication, February 9, 2016; 10.1038/tpj.2015.96

Abstract | Full Text

ABCC3 genetic variants are associated with postoperative morphine-induced respiratory depression and morphine pharmacokinetics in children

V Chidambaran, R Venkatasubramanian, X Zhang, L J Martin, J Niu, T Mizuno, T Fukuda, J Meller, A A Vinks and S Sadhasivam

Pharmacogenomics J 2016 17: 162-169; advance online publication, January 26, 2016; 10.1038/tpj.2015.98

Abstract | Full Text

Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population

C-C Chang, C-C Ng, C-L Too, S-E Choon, C-K Lee, W-H Chung, S H Hussein, K-S Lim and S Murad

Pharmacogenomics J 2016 17: 170-173; advance online publication, March 1, 2016; 10.1038/tpj.2016.10

Abstract | Full Text

A pharmacogenomic study on the pharmacokinetics of tacrolimus in healthy subjects using the DMETTM Plus platform

Y Choi, F Jiang, H An, H J Park, J H Choi and H Lee

Pharmacogenomics J 2016 17: 174-179; advance online publication, February 16, 2016; 10.1038/tpj.2015.99

Abstract | Full Text

A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment

H-W Park, S Tse, W Yang, H W Kelly, S C Kaste, C-H Pui, M V Relling and K G Tantisira

Pharmacogenomics J 2016 17: 180-185; advance online publication, February 9, 2016; 10.1038/tpj.2015.92

Abstract | Full Text

Role of the C1858T polymorphism of protein tyrosine phosphatase non-receptor type 22 (PTPN22) in children and adolescents with type 1 diabetes

A Blasetti, C Di Giulio, S Tumini, M Provenzano, D Rapino, L Comegna, G Prezioso, R Chiuri, S Franchini, F Chiarelli and L Stuppia

Pharmacogenomics J 2016 17: 186-191; advance online publication, February 23, 2016; 10.1038/tpj.2016.6

Abstract | Full Text

A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials

S de Denus, J L Rouleau, D L Mann, G S Huggins, T P Cappola, S H Shah, J Keleti, Y F Zada, S Provost, A Bardhadi, M S Phillips, V Normand, I Mongrain and M-P Dubé

Pharmacogenomics J 2016 17: 192-200; advance online publication, March 1, 2016; 10.1038/tpj.2016.4

Abstract | Full Text

ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout

R L Roberts, M C Wallace, A J Phipps-Green, R Topless, J M Drake, P Tan, N Dalbeth, T R Merriman and L K Stamp

Pharmacogenomics J 2017 17: 201-203; advance online publication, January 26, 2016; 10.1038/tpj.2015.101

Abstract | Full Text

Consensus Article


The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy

Q Feng, W Q Wei, C P Chung, R T Levinson, L Bastarache, J C Denny and C M Stein

Pharmacogenomics J 2016 17: 204-208; advance online publication, February 23, 2016; 10.1038/tpj.2016.3

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

1 comment:

Scitech Central said...

Journal of Genomic Medicine and Pharmacogenomics
provides a platform to integrate the most recent development and ideas in the
field of genomics and bioinformatics.
Journal of Genomic Medicine and Pharmacogenomics